Table 5.
Univariate Analysis of Overall Survival (OS) and Progression-Free Survival (PFS)
| p Value | ||
|---|---|---|
| OS | PFS | |
| pCR or not | 0.054 | 0.013 |
| cCR or not | 0.056 | 0.062 |
| Age | 0.046 | 0.438 |
| Race | 0.094 | 0.211 |
| Body mass index | 0.840 | 0.477 |
| Smoking or not | 0.074 | 0.016 |
| Family history of cancer | 0.819 | 0.660 |
| Comorbidity or not | 0.433 | 0.397 |
| Tumor size at diagnosis | 0.029 | 0.080 |
| Tumor after NACT | 0.034 | 0.000 |
| Nodes at diagnosis | 0.138 | 0.082 |
| Nodes after NACT | 0.000 | 0.000 |
| LVI | 0.000 | 0.000 |
| Tumor grade | 0.911 | 0.344 |
| Tumor type | 0.200 | 0.123 |
| Change of receptors | 0.791 | 0.832 |
| Tumor sides | 0.559 | 0.755 |
| Regimens of NACT | 0.230 | 0.689 |
| Side effects | 0.268 | 0.185 |
| Type of surgery | 0.028 | 0.039 |
| ACT | 0.005 | 0.078 |
| ART | 0.102 | 0.163 |
pCR, pathological complete response; NACT, neoadjuvant chemotherapy; LVI, lymph vascular invasion; ACT, adjuvant chemotherapy; ART, adjuvant radiotherapy.